tradingkey.logo
tradingkey.logo

Sol Gel Technologies Ltd

SLGL
View Detailed Chart
67.790USD
-9.960-12.81%
Close 03/30, 16:00ETQuotes delayed by 15 min
121.92MMarket Cap
LossP/E TTM

Sol Gel Technologies Ltd

67.790
-9.960-12.81%
Intraday
1m
30m
1h
D
W
M
D

Today

-12.81%

5 Days

-7.10%

1 Month

-25.98%

6 Months

+135.87%

Year to Date

+60.87%

1 Year

+1132.55%

View Detailed Chart

Key Insights

Sol Gel Technologies Ltd's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 120 out of 391 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 110.00.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Sol Gel Technologies Ltd's Score

Industry at a Glance

Industry Ranking
120 / 391
Overall Ranking
239 / 4542
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Sol Gel Technologies Ltd Highlights

StrengthsRisks
Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 1147.62% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 19.39M.
Undervalued
The company’s latest PE is -36.01, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 634.85K shares, decreasing 40.95% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 0.00 shares of this stock.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
110.000
Target Price
+41.48%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Sol Gel Technologies Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Sol Gel Technologies Ltd Info

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
Ticker SymbolSLGL
CompanySol Gel Technologies Ltd
CEO
Websitehttp://www.sol-gel.com
KeyAI